HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

Aclarion, Inc.

Contributing Author

Recent Articles by Aclarion, Inc.

Mar-19
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan ACON GlobeNewswire
Mar-19
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts ACON GlobeNewswire
Mar-17
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet ACON GlobeNewswire
Mar-12
Aclarion CEO Brent Ness to Attend LSI USA 2026 ACON GlobeNewswire
Feb-05
Aclarion Publishes 2026 Shareholder Letter from the Chairman ACON -12.59% GlobeNewswire
Feb-03
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation ACON GlobeNewswire
Jan-13
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 ACON -6.87% GlobeNewswire
Jan-08
Aclarion Provides 2025 Update and 2026 Corporate Outlook ACON +42.09% GlobeNewswire
Jan-06
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data ACON GlobeNewswire
Dec-04
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) ACON +5.55% GlobeNewswire
Dec-02
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. ACON +10.31% GlobeNewswire
Nov-05
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion ACON GlobeNewswire
Oct-22
Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-14
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst ACON -7.64% GlobeNewswire
Oct-13
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference ACON +12.71% GlobeNewswire
Oct-07
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-01
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers ACON GlobeNewswire
Sep-25
First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial ACON GlobeNewswire
Sep-03
Aclarion Appoints Greg Gould as Chief Financial Officer ACON GlobeNewswire
Aug-05
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts ACON +5.71% GlobeNewswire
Jul-07
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders ACON GlobeNewswire
Jun-25
First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial ACON GlobeNewswire
Jun-24
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum ACON GlobeNewswire
Jun-10
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site ACON GlobeNewswire
May-20
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site ACON GlobeNewswire
May-12
Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON +7.04% GlobeNewswire
May-05
Aclarion Welcomes Advocate Health as CLARITY Trial Site ACON GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)